US Venture Partners X L.P. is 10% Owner at eFFECTOR Therapeutics, Inc. (EFTR). They have made 6 open-market trades across 2 companies since 2020, most recently 2022-07-22.
CIK 0001440514
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.9M since 2020, against 5 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 60% | 100% |
| Avg Move | -6.6% | -10.7% | -41.1% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EFTR | SELL | 2022-07-20 | 2022-07-22 | $0.96 | $20K | -16.2% | -37.8% | -37.2% |
| EFTR | SELL | 2022-07-15 | 2022-07-19 | $1.10 | $76K | -18.8% | -32.6% | -39.8% |
| EFTR | SELL | 2022-05-12 | 2022-05-16 | $1.85 | $86K | +5.9% | -16.7% | -59.4% |
| EFTR | SELL | 2021-12-02 | 2021-12-06 | $5.68 | $46K | -6.5% | +1.6% | -43.3% |
| EFTR | SELL | 2021-11-23 | 2021-11-26 | $7.34 | $414K | +2.8% | +31.9% | -25.9% |
| NARI | BUY | 2020-05-27 | 2020-05-27 | $19.00 | $1.9M | +20.5% | +10.6% | +66.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.